Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
LONDON and RALEIGH, N.C., Feb. 15, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq:VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the fourth quarter and full year ended December 31, 2023 on Thursday, February 29, 2024 and host an investment community conference call at 9:00 a.m. EST / 2:00 p.m. GMT to discuss these financial results and provide a corporate update.